Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35.2K Sell
16,801
-50
-0.3% -$10.7K ﹤0.01% 614
2026
Q1
$47.2K Buy
16,851
+34
+0.2% +$8.32K ﹤0.01% 523
2025
Q4
$43.1K Sell
16,817
-23
-0.1% -$5.78K ﹤0.01% 570
2025
Q3
$48.1K Buy
16,840
+54
+0.3% +$12.9K ﹤0.01% 564
2025
Q2
$34.2K Buy
16,786
+18
+0.1% +$4.19K ﹤0.01% 612
2025
Q1
$29.2K Hold
16,768
﹤0.01% 612
2024
Q4
$28K Hold
16,768
﹤0.01% 614
2024
Q3
$28.9K Buy
16,768
+16,713
+30,387% +$3.91M ﹤0.01% 593
2024
Q2
$12.1K Hold
55
﹤0.01% 712
2024
Q1
$12.4K Buy
+55
New +$12.4K ﹤0.01% 463

Other funds holding STE

LRI Investments's STE Position: Q2 2026 in Review

LRI Investments reduced its Steris (STE) stake by 0.3% in Q2 2026, selling an estimated $10.7K and leaving 16,801 shares worth $35.2K. The position accounts for ﹤0.01% of the portfolio, ranked #614.

LRI Investments first reported a position in STE in Q1 2024 and has held it in 10 quarters since. The position peaked at $48.1K in Q3 2025. 285 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • LRI Investments held 16,801 shares of Steris worth $35.2K as of Q2 2026.
  • LRI Investments sold 50 Steris shares in Q2 2026, an estimated $10.7K.
  • Steris made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #614 holding.
  • LRI Investments first reported a position in Steris in Q1 2024 and has held it in 10 quarters since.
  • LRI Investments's Steris position peaked at $48.1K in Q3 2025.
  • 285 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.